nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—ABCB1—Lisinopril—systemic scleroderma	0.176	0.328	CbGbCtD
Nizatidine—ABCB1—Captopril—systemic scleroderma	0.132	0.246	CbGbCtD
Nizatidine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.104	0.194	CbGbCtD
Nizatidine—ABCB1—Prednisone—systemic scleroderma	0.083	0.155	CbGbCtD
Nizatidine—ABCB1—Methotrexate—systemic scleroderma	0.0416	0.0776	CbGbCtD
Nizatidine—Chest pain—Leflunomide—systemic scleroderma	0.000987	0.00213	CcSEcCtD
Nizatidine—Myalgia—Leflunomide—systemic scleroderma	0.000987	0.00213	CcSEcCtD
Nizatidine—Anxiety—Leflunomide—systemic scleroderma	0.000984	0.00212	CcSEcCtD
Nizatidine—Constipation—Captopril—systemic scleroderma	0.000982	0.00212	CcSEcCtD
Nizatidine—Flatulence—Lisinopril—systemic scleroderma	0.000982	0.00212	CcSEcCtD
Nizatidine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000981	0.00212	CcSEcCtD
Nizatidine—Tension—Lisinopril—systemic scleroderma	0.000978	0.00211	CcSEcCtD
Nizatidine—Nervousness—Lisinopril—systemic scleroderma	0.000968	0.00209	CcSEcCtD
Nizatidine—Dry mouth—Leflunomide—systemic scleroderma	0.000966	0.00208	CcSEcCtD
Nizatidine—Cough—Mycophenolic acid—systemic scleroderma	0.000965	0.00208	CcSEcCtD
Nizatidine—Back pain—Lisinopril—systemic scleroderma	0.000964	0.00208	CcSEcCtD
Nizatidine—Vomiting—Pentoxifylline—systemic scleroderma	0.000963	0.00208	CcSEcCtD
Nizatidine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000959	0.00207	CcSEcCtD
Nizatidine—Rash—Pentoxifylline—systemic scleroderma	0.000955	0.00206	CcSEcCtD
Nizatidine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000955	0.00206	CcSEcCtD
Nizatidine—Headache—Pentoxifylline—systemic scleroderma	0.000949	0.00205	CcSEcCtD
Nizatidine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000946	0.00204	CcSEcCtD
Nizatidine—Feeling abnormal—Captopril—systemic scleroderma	0.000946	0.00204	CcSEcCtD
Nizatidine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000942	0.00203	CcSEcCtD
Nizatidine—Myalgia—Mycophenolic acid—systemic scleroderma	0.000942	0.00203	CcSEcCtD
Nizatidine—Infection—Leflunomide—systemic scleroderma	0.00094	0.00203	CcSEcCtD
Nizatidine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000939	0.00202	CcSEcCtD
Nizatidine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000939	0.00202	CcSEcCtD
Nizatidine—Asthenia—Mometasone—systemic scleroderma	0.000938	0.00202	CcSEcCtD
Nizatidine—Irritability—Prednisone—systemic scleroderma	0.000938	0.00202	CcSEcCtD
Nizatidine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000927	0.002	CcSEcCtD
Nizatidine—Pruritus—Mometasone—systemic scleroderma	0.000925	0.00199	CcSEcCtD
Nizatidine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000921	0.00199	CcSEcCtD
Nizatidine—Anaemia—Lisinopril—systemic scleroderma	0.000921	0.00199	CcSEcCtD
Nizatidine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000915	0.00197	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000913	0.00197	CcSEcCtD
Nizatidine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00091	0.00196	CcSEcCtD
Nizatidine—Abdominal pain—Captopril—systemic scleroderma	0.000908	0.00196	CcSEcCtD
Nizatidine—Body temperature increased—Captopril—systemic scleroderma	0.000908	0.00196	CcSEcCtD
Nizatidine—Anorexia—Leflunomide—systemic scleroderma	0.000902	0.00195	CcSEcCtD
Nizatidine—Nausea—Pentoxifylline—systemic scleroderma	0.0009	0.00194	CcSEcCtD
Nizatidine—Infection—Mycophenolic acid—systemic scleroderma	0.000897	0.00193	CcSEcCtD
Nizatidine—Diarrhoea—Mometasone—systemic scleroderma	0.000895	0.00193	CcSEcCtD
Nizatidine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000884	0.00191	CcSEcCtD
Nizatidine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000873	0.00188	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00087	0.00188	CcSEcCtD
Nizatidine—Cough—Lisinopril—systemic scleroderma	0.00087	0.00188	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000865	0.00187	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000862	0.00186	CcSEcCtD
Nizatidine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000861	0.00186	CcSEcCtD
Nizatidine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00086	0.00186	CcSEcCtD
Nizatidine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000857	0.00185	CcSEcCtD
Nizatidine—Insomnia—Leflunomide—systemic scleroderma	0.000856	0.00185	CcSEcCtD
Nizatidine—Chest pain—Lisinopril—systemic scleroderma	0.000848	0.00183	CcSEcCtD
Nizatidine—Myalgia—Lisinopril—systemic scleroderma	0.000848	0.00183	CcSEcCtD
Nizatidine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000848	0.00183	CcSEcCtD
Nizatidine—Anxiety—Lisinopril—systemic scleroderma	0.000845	0.00182	CcSEcCtD
Nizatidine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000845	0.00182	CcSEcCtD
Nizatidine—Dyspepsia—Leflunomide—systemic scleroderma	0.000833	0.0018	CcSEcCtD
Nizatidine—Vomiting—Mometasone—systemic scleroderma	0.000831	0.00179	CcSEcCtD
Nizatidine—Dry mouth—Lisinopril—systemic scleroderma	0.00083	0.00179	CcSEcCtD
Nizatidine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000826	0.00178	CcSEcCtD
Nizatidine—Rash—Mometasone—systemic scleroderma	0.000824	0.00178	CcSEcCtD
Nizatidine—Asthenia—Captopril—systemic scleroderma	0.000824	0.00178	CcSEcCtD
Nizatidine—Dermatitis—Mometasone—systemic scleroderma	0.000824	0.00178	CcSEcCtD
Nizatidine—Decreased appetite—Leflunomide—systemic scleroderma	0.000823	0.00177	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000823	0.00177	CcSEcCtD
Nizatidine—Confusional state—Lisinopril—systemic scleroderma	0.00082	0.00177	CcSEcCtD
Nizatidine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00082	0.00177	CcSEcCtD
Nizatidine—Headache—Mometasone—systemic scleroderma	0.000819	0.00177	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000817	0.00176	CcSEcCtD
Nizatidine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000817	0.00176	CcSEcCtD
Nizatidine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000813	0.00175	CcSEcCtD
Nizatidine—Pruritus—Captopril—systemic scleroderma	0.000812	0.00175	CcSEcCtD
Nizatidine—Pain—Leflunomide—systemic scleroderma	0.000809	0.00175	CcSEcCtD
Nizatidine—Constipation—Leflunomide—systemic scleroderma	0.000809	0.00175	CcSEcCtD
Nizatidine—Infection—Lisinopril—systemic scleroderma	0.000808	0.00174	CcSEcCtD
Nizatidine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000807	0.00174	CcSEcCtD
Nizatidine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000803	0.00173	CcSEcCtD
Nizatidine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000796	0.00172	CcSEcCtD
Nizatidine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000795	0.00171	CcSEcCtD
Nizatidine—Abdominal pain—Azathioprine—systemic scleroderma	0.000792	0.00171	CcSEcCtD
Nizatidine—Body temperature increased—Azathioprine—systemic scleroderma	0.000792	0.00171	CcSEcCtD
Nizatidine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000786	0.0017	CcSEcCtD
Nizatidine—Diarrhoea—Captopril—systemic scleroderma	0.000786	0.00169	CcSEcCtD
Nizatidine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000785	0.00169	CcSEcCtD
Nizatidine—Irritability—Methotrexate—systemic scleroderma	0.000784	0.00169	CcSEcCtD
Nizatidine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000782	0.00169	CcSEcCtD
Nizatidine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00078	0.00168	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00078	0.00168	CcSEcCtD
Nizatidine—Nausea—Mometasone—systemic scleroderma	0.000777	0.00167	CcSEcCtD
Nizatidine—Anorexia—Lisinopril—systemic scleroderma	0.000775	0.00167	CcSEcCtD
Nizatidine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000774	0.00167	CcSEcCtD
Nizatidine—Pain—Mycophenolic acid—systemic scleroderma	0.000772	0.00166	CcSEcCtD
Nizatidine—Constipation—Mycophenolic acid—systemic scleroderma	0.000772	0.00166	CcSEcCtD
Nizatidine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000762	0.00164	CcSEcCtD
Nizatidine—Dizziness—Captopril—systemic scleroderma	0.000759	0.00164	CcSEcCtD
Nizatidine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000756	0.00163	CcSEcCtD
Nizatidine—Urticaria—Leflunomide—systemic scleroderma	0.000752	0.00162	CcSEcCtD
Nizatidine—Abdominal pain—Leflunomide—systemic scleroderma	0.000748	0.00161	CcSEcCtD
Nizatidine—Body temperature increased—Leflunomide—systemic scleroderma	0.000748	0.00161	CcSEcCtD
Nizatidine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000744	0.0016	CcSEcCtD
Nizatidine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000743	0.0016	CcSEcCtD
Nizatidine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000743	0.0016	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000741	0.0016	CcSEcCtD
Nizatidine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000741	0.0016	CcSEcCtD
Nizatidine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000738	0.00159	CcSEcCtD
Nizatidine—Insomnia—Lisinopril—systemic scleroderma	0.000736	0.00159	CcSEcCtD
Nizatidine—Vomiting—Captopril—systemic scleroderma	0.00073	0.00157	CcSEcCtD
Nizatidine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000727	0.00157	CcSEcCtD
Nizatidine—Rash—Captopril—systemic scleroderma	0.000724	0.00156	CcSEcCtD
Nizatidine—Dermatitis—Captopril—systemic scleroderma	0.000723	0.00156	CcSEcCtD
Nizatidine—Somnolence—Lisinopril—systemic scleroderma	0.000723	0.00156	CcSEcCtD
Nizatidine—Headache—Captopril—systemic scleroderma	0.000719	0.00155	CcSEcCtD
Nizatidine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000718	0.00155	CcSEcCtD
Nizatidine—Dyspepsia—Lisinopril—systemic scleroderma	0.000716	0.00154	CcSEcCtD
Nizatidine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000714	0.00154	CcSEcCtD
Nizatidine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000714	0.00154	CcSEcCtD
Nizatidine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000713	0.00154	CcSEcCtD
Nizatidine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000708	0.00153	CcSEcCtD
Nizatidine—Decreased appetite—Lisinopril—systemic scleroderma	0.000707	0.00152	CcSEcCtD
Nizatidine—Eosinophilia—Methotrexate—systemic scleroderma	0.000703	0.00152	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000702	0.00151	CcSEcCtD
Nizatidine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000698	0.0015	CcSEcCtD
Nizatidine—Pain—Lisinopril—systemic scleroderma	0.000695	0.0015	CcSEcCtD
Nizatidine—Constipation—Lisinopril—systemic scleroderma	0.000695	0.0015	CcSEcCtD
Nizatidine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000689	0.00149	CcSEcCtD
Nizatidine—Diarrhoea—Azathioprine—systemic scleroderma	0.000686	0.00148	CcSEcCtD
Nizatidine—Nausea—Captopril—systemic scleroderma	0.000682	0.00147	CcSEcCtD
Nizatidine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000679	0.00146	CcSEcCtD
Nizatidine—Asthenia—Leflunomide—systemic scleroderma	0.000679	0.00146	CcSEcCtD
Nizatidine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00067	0.00145	CcSEcCtD
Nizatidine—Pruritus—Leflunomide—systemic scleroderma	0.00067	0.00144	CcSEcCtD
Nizatidine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000665	0.00143	CcSEcCtD
Nizatidine—Dizziness—Azathioprine—systemic scleroderma	0.000663	0.00143	CcSEcCtD
Nizatidine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000654	0.00141	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000649	0.0014	CcSEcCtD
Nizatidine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000648	0.0014	CcSEcCtD
Nizatidine—Diarrhoea—Leflunomide—systemic scleroderma	0.000648	0.0014	CcSEcCtD
Nizatidine—Urticaria—Lisinopril—systemic scleroderma	0.000646	0.00139	CcSEcCtD
Nizatidine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000644	0.00139	CcSEcCtD
Nizatidine—Abdominal pain—Lisinopril—systemic scleroderma	0.000643	0.00139	CcSEcCtD
Nizatidine—Body temperature increased—Lisinopril—systemic scleroderma	0.000643	0.00139	CcSEcCtD
Nizatidine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000639	0.00138	CcSEcCtD
Nizatidine—Vomiting—Azathioprine—systemic scleroderma	0.000637	0.00137	CcSEcCtD
Nizatidine—Pneumonia—Methotrexate—systemic scleroderma	0.000637	0.00137	CcSEcCtD
Nizatidine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000633	0.00137	CcSEcCtD
Nizatidine—Rash—Azathioprine—systemic scleroderma	0.000632	0.00136	CcSEcCtD
Nizatidine—Dermatitis—Azathioprine—systemic scleroderma	0.000631	0.00136	CcSEcCtD
Nizatidine—Headache—Azathioprine—systemic scleroderma	0.000628	0.00135	CcSEcCtD
Nizatidine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000627	0.00135	CcSEcCtD
Nizatidine—Dizziness—Leflunomide—systemic scleroderma	0.000626	0.00135	CcSEcCtD
Nizatidine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000619	0.00134	CcSEcCtD
Nizatidine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000618	0.00133	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000615	0.00133	CcSEcCtD
Nizatidine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000609	0.00131	CcSEcCtD
Nizatidine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000609	0.00131	CcSEcCtD
Nizatidine—Sweating—Methotrexate—systemic scleroderma	0.000607	0.00131	CcSEcCtD
Nizatidine—Vomiting—Leflunomide—systemic scleroderma	0.000602	0.0013	CcSEcCtD
Nizatidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000597	0.00129	CcSEcCtD
Nizatidine—Rash—Leflunomide—systemic scleroderma	0.000597	0.00129	CcSEcCtD
Nizatidine—Dermatitis—Leflunomide—systemic scleroderma	0.000596	0.00129	CcSEcCtD
Nizatidine—Nausea—Azathioprine—systemic scleroderma	0.000595	0.00128	CcSEcCtD
Nizatidine—Headache—Leflunomide—systemic scleroderma	0.000593	0.00128	CcSEcCtD
Nizatidine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000587	0.00127	CcSEcCtD
Nizatidine—Asthenia—Lisinopril—systemic scleroderma	0.000583	0.00126	CcSEcCtD
Nizatidine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000583	0.00126	CcSEcCtD
Nizatidine—Pruritus—Lisinopril—systemic scleroderma	0.000575	0.00124	CcSEcCtD
Nizatidine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000574	0.00124	CcSEcCtD
Nizatidine—Rash—Mycophenolic acid—systemic scleroderma	0.000569	0.00123	CcSEcCtD
Nizatidine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000569	0.00123	CcSEcCtD
Nizatidine—Hepatitis—Methotrexate—systemic scleroderma	0.000568	0.00123	CcSEcCtD
Nizatidine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000566	0.00122	CcSEcCtD
Nizatidine—Headache—Mycophenolic acid—systemic scleroderma	0.000566	0.00122	CcSEcCtD
Nizatidine—Pharyngitis—Methotrexate—systemic scleroderma	0.000564	0.00122	CcSEcCtD
Nizatidine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000563	0.00121	CcSEcCtD
Nizatidine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000563	0.00121	CcSEcCtD
Nizatidine—Nausea—Leflunomide—systemic scleroderma	0.000562	0.00121	CcSEcCtD
Nizatidine—Diarrhoea—Lisinopril—systemic scleroderma	0.000556	0.0012	CcSEcCtD
Nizatidine—Anaemia—Prednisone—systemic scleroderma	0.000547	0.00118	CcSEcCtD
Nizatidine—Dizziness—Lisinopril—systemic scleroderma	0.000538	0.00116	CcSEcCtD
Nizatidine—Nausea—Mycophenolic acid—systemic scleroderma	0.000536	0.00116	CcSEcCtD
Nizatidine—Vomiting—Lisinopril—systemic scleroderma	0.000517	0.00111	CcSEcCtD
Nizatidine—Rash—Lisinopril—systemic scleroderma	0.000513	0.00111	CcSEcCtD
Nizatidine—Convulsion—Prednisone—systemic scleroderma	0.000513	0.00111	CcSEcCtD
Nizatidine—Dermatitis—Lisinopril—systemic scleroderma	0.000512	0.0011	CcSEcCtD
Nizatidine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000511	0.0011	CcSEcCtD
Nizatidine—Headache—Lisinopril—systemic scleroderma	0.000509	0.0011	CcSEcCtD
Nizatidine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000504	0.00109	CcSEcCtD
Nizatidine—Myalgia—Prednisone—systemic scleroderma	0.000504	0.00109	CcSEcCtD
Nizatidine—Anxiety—Prednisone—systemic scleroderma	0.000502	0.00108	CcSEcCtD
Nizatidine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000488	0.00105	CcSEcCtD
Nizatidine—Nausea—Lisinopril—systemic scleroderma	0.000483	0.00104	CcSEcCtD
Nizatidine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000483	0.00104	CcSEcCtD
Nizatidine—Infection—Prednisone—systemic scleroderma	0.00048	0.00103	CcSEcCtD
Nizatidine—Back pain—Methotrexate—systemic scleroderma	0.000478	0.00103	CcSEcCtD
Nizatidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000471	0.00102	CcSEcCtD
Nizatidine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000467	0.00101	CcSEcCtD
Nizatidine—Anorexia—Prednisone—systemic scleroderma	0.00046	0.000993	CcSEcCtD
Nizatidine—Anaemia—Methotrexate—systemic scleroderma	0.000457	0.000986	CcSEcCtD
Nizatidine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000453	0.000977	CcSEcCtD
Nizatidine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000969	CcSEcCtD
Nizatidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000968	CcSEcCtD
Nizatidine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000963	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00044	0.000949	CcSEcCtD
Nizatidine—Insomnia—Prednisone—systemic scleroderma	0.000437	0.000942	CcSEcCtD
Nizatidine—Cough—Methotrexate—systemic scleroderma	0.000432	0.000931	CcSEcCtD
Nizatidine—Convulsion—Methotrexate—systemic scleroderma	0.000429	0.000924	CcSEcCtD
Nizatidine—Dyspepsia—Prednisone—systemic scleroderma	0.000425	0.000917	CcSEcCtD
Nizatidine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000423	0.000913	CcSEcCtD
Nizatidine—Chest pain—Methotrexate—systemic scleroderma	0.000421	0.000908	CcSEcCtD
Nizatidine—Myalgia—Methotrexate—systemic scleroderma	0.000421	0.000908	CcSEcCtD
Nizatidine—Decreased appetite—Prednisone—systemic scleroderma	0.00042	0.000905	CcSEcCtD
Nizatidine—Constipation—Prednisone—systemic scleroderma	0.000413	0.000891	CcSEcCtD
Nizatidine—Confusional state—Methotrexate—systemic scleroderma	0.000407	0.000878	CcSEcCtD
Nizatidine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000404	0.00087	CcSEcCtD
Nizatidine—Infection—Methotrexate—systemic scleroderma	0.000401	0.000865	CcSEcCtD
Nizatidine—Feeling abnormal—Prednisone—systemic scleroderma	0.000398	0.000858	CcSEcCtD
Nizatidine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000395	0.000852	CcSEcCtD
Nizatidine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000395	0.000852	CcSEcCtD
Nizatidine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00039	0.000841	CcSEcCtD
Nizatidine—Anorexia—Methotrexate—systemic scleroderma	0.000385	0.00083	CcSEcCtD
Nizatidine—Urticaria—Prednisone—systemic scleroderma	0.000384	0.000827	CcSEcCtD
Nizatidine—Abdominal pain—Prednisone—systemic scleroderma	0.000382	0.000823	CcSEcCtD
Nizatidine—Body temperature increased—Prednisone—systemic scleroderma	0.000382	0.000823	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000368	0.000793	CcSEcCtD
Nizatidine—Insomnia—Methotrexate—systemic scleroderma	0.000365	0.000787	CcSEcCtD
Nizatidine—Somnolence—Methotrexate—systemic scleroderma	0.000359	0.000774	CcSEcCtD
Nizatidine—Dyspepsia—Methotrexate—systemic scleroderma	0.000355	0.000766	CcSEcCtD
Nizatidine—Decreased appetite—Methotrexate—systemic scleroderma	0.000351	0.000757	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000348	0.000751	CcSEcCtD
Nizatidine—Asthenia—Prednisone—systemic scleroderma	0.000347	0.000747	CcSEcCtD
Nizatidine—Pain—Methotrexate—systemic scleroderma	0.000345	0.000744	CcSEcCtD
Nizatidine—Pruritus—Prednisone—systemic scleroderma	0.000342	0.000737	CcSEcCtD
Nizatidine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000333	0.000717	CcSEcCtD
Nizatidine—Diarrhoea—Prednisone—systemic scleroderma	0.00033	0.000713	CcSEcCtD
Nizatidine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00033	0.000712	CcSEcCtD
Nizatidine—Urticaria—Methotrexate—systemic scleroderma	0.000321	0.000691	CcSEcCtD
Nizatidine—Dizziness—Prednisone—systemic scleroderma	0.000319	0.000689	CcSEcCtD
Nizatidine—Abdominal pain—Methotrexate—systemic scleroderma	0.000319	0.000688	CcSEcCtD
Nizatidine—Body temperature increased—Methotrexate—systemic scleroderma	0.000319	0.000688	CcSEcCtD
Nizatidine—Vomiting—Prednisone—systemic scleroderma	0.000307	0.000662	CcSEcCtD
Nizatidine—Rash—Prednisone—systemic scleroderma	0.000305	0.000657	CcSEcCtD
Nizatidine—Dermatitis—Prednisone—systemic scleroderma	0.000304	0.000656	CcSEcCtD
Nizatidine—Headache—Prednisone—systemic scleroderma	0.000303	0.000652	CcSEcCtD
Nizatidine—Asthenia—Methotrexate—systemic scleroderma	0.00029	0.000625	CcSEcCtD
Nizatidine—Nausea—Prednisone—systemic scleroderma	0.000287	0.000619	CcSEcCtD
Nizatidine—Pruritus—Methotrexate—systemic scleroderma	0.000286	0.000616	CcSEcCtD
Nizatidine—Diarrhoea—Methotrexate—systemic scleroderma	0.000276	0.000596	CcSEcCtD
Nizatidine—Dizziness—Methotrexate—systemic scleroderma	0.000267	0.000576	CcSEcCtD
Nizatidine—Vomiting—Methotrexate—systemic scleroderma	0.000257	0.000553	CcSEcCtD
Nizatidine—Rash—Methotrexate—systemic scleroderma	0.000255	0.000549	CcSEcCtD
Nizatidine—Dermatitis—Methotrexate—systemic scleroderma	0.000254	0.000548	CcSEcCtD
Nizatidine—Headache—Methotrexate—systemic scleroderma	0.000253	0.000545	CcSEcCtD
Nizatidine—Nausea—Methotrexate—systemic scleroderma	0.00024	0.000517	CcSEcCtD
